Clemondo Group AB (publ)
F:N17
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Clemondo Group AB (publ)
F:N17
|
SE |
|
F
|
Forvia SE
XMUN:FAU
|
FR |
|
J
|
Jervois Global Ltd
XMUN:IHS
|
AU |
|
Azienda Bresciana Petroli Nocivelli SpA
F:9UZ
|
IT |
|
P
|
ProMIS Neurosciences Inc
F:23J0
|
CA |
|
A
|
Ackermans & Van Haaren NV
DUS:B3K
|
BE |
|
Shoper SA
F:8FF
|
PL |
|
ForFarmers NV
OTC:FRFBF
|
NL |
|
L
|
Legend Power Systems Inc
OTC:LPSIF
|
CA |
|
B
|
Baxter International Inc
XMUN:BTL
|
US |
Wall St Price Targets
N17 Price Targets Summary
Clemondo Group AB (publ)
According to Wall Street analysts, the average 1-year price target for N17 is 1.03 EUR with a low forecast of 1.02 EUR and a high forecast of 1.06 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is N17's stock price target?
Price Target
1.03
EUR
According to Wall Street analysts, the average 1-year price target for N17 is 1.03 EUR with a low forecast of 1.02 EUR and a high forecast of 1.06 EUR.
What is the Revenue forecast for Clemondo Group AB (publ)?
Projected CAGR
10%
Over the last 14 years, the compound annual growth rate for Revenue has been 10%. The projected CAGR for the next 3 years is 10%.
What is the Operating Income forecast for Clemondo Group AB (publ)?
Projected CAGR
35%
Over the last 14 years, the compound annual growth rate for Operating Income has been 1%. The projected CAGR for the next 3 years is 35%.
What is the Net Income forecast for Clemondo Group AB (publ)?
Projected CAGR
37%
Over the last 14 years, the compound annual growth rate for Net Income has been 0%. The projected CAGR for the next 3 years is 37%.
